Home Analyst Ratings SQZ Biotechnologies gets fresh Outperform rating from Evercore ISI Group

SQZ Biotechnologies [SQZ] gets fresh Outperform rating from Evercore ISI Group

Evercore ISI Group launched its SQZ Biotechnologies [SQZ] rating to the equivalent of Outperform and assigned the price target of $nan, in a research note dated 2021-01-08. That figure represents around a nan% premium from where the company’s shares closed on Thursday. Some new analysts also started their coverage, with BTIG Research’s analysts assigning the shares to “a Buy” rating in a research note to investors issued in late November. Meanwhile, BofA Securities had launched its coverage on SQZ with “Buy”, in a research note produced for clients November 24, 2020.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now. 

SQZ Price Performance

On Wall Street, SQZ Biotechnologies Company [NYSE:SQZ] finished Thursday’s session down -1.94% at $29.32. The stock went up to $30.52 at the same session while its lowest single day price was $28.1495. In the last five days, it saw a fall of about -2.40%, SQZ Biotechnologies Company shares gained by almost 1.17% since the beginning of the year. However, the share price has dropped to as low as -19.65% below its one year high.

5 Stocks Under $10 That Are Poised to Take Off

Investing in stocks under $10 could significantly increase the returns on your portfolio, especially if you pick the right stocks! Within this report you will find 5 top stocks that offer investors huge upside potential and the best bang for their buck.

Add them to your watchlist before they take off!

Get the Top 5 Stocks Now!

Sponsored

SQZ Stock Support And Resistance Levels

On the 24-hour scale, the immediate backing is perceived around 28.14 level, and in case of violation of this particular level, it will cause more drop to 26.96 level. On the upper level, 31.70 is still the key resistance. The stock may increase to the subsequent resistance at 30.51. The Relative Strength Index (RSI) pinned on the 14-day chart is 55.83, implying a neutral technical stance while the MACD stands at 0.67, meaning price will decrease in the next trading period. Percent R indicator moved to 52.85%, implying low price movement. Stochastic %K at 47.88% suggest selling the stock.

What is the short interest in SQZ Biotechnologies Company?

Short interest in the SQZ Biotechnologies Company stock has plunged, decreasing by 68130.0 shares to total 79270.0 shares on Dec 14, 2020. The interest had seen shares on Nov 12, 2020 stand at 11140.0, data from Yahoo Finance shows. The increase of 85.95% suggests the stock saw some increased bearish sentiment. The stock’s days to cover (short ratio) moved to while the shorted shares account for just 0.43% of the overall float for the stock.

SQZ Biotechnologies Company’s Biggest Shareholders: Who Owns SQZ Biotechnologies Company [SQZ]?

Filings by Temasek Holdings Pte Ltd. showed that the firm now holds a total of 2,513,924 shares or roughly 10.49% of the outstanding SQZ shares. This means their shares have increased by 625,000 from the 2,513,924 the investor reportedly held in its prior 13-F filing. With the conclusion of the purchase, Invus Public Equities Advisors LL updated stake is worth $49,795,548.

SQZ Earnings Forecast For The Current Quarter

SQZ Biotechnologies Company [SQZ] is expected to report earnings results for the quarter ending on Dec 2020. Consensus estimates give the company expected revenues of $3.5M and an earnings per share of -$0.75 for Dec 2020. Looking further ahead, the company is expected to report revenue of $8.94M at an EPS of -$0.4 for Mar 2021. The estimates represent -3.00% and 52.90% in the company’s revenue and earnings per share, respectively, on a year-on-year basis.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now. 

SQZ Earnings Estimates For The Current Year

For the financial year, SQZ Biotechnologies Company [NYSE:SQZ] is expected to bring in revenue of $19.38M. In terms of EPS for the 2020, estimate put it at -5.05.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

Torchlight Energy Resources Inc. (TRCH) stock surged during current market trading. Here’s to know why?

Torchlight Energy Resources Inc. (NASDAQ: TRCH) stock gained by 41.33% in the current market trading session. Torchlight Energy Resources is a vast growing oil...

The9 Ltd. (NCTY) stock declined during pre-market trading. Here’s the update

The9 Ltd. (NASDAQ: NCTY) stock plunged by 12% at the last close while the NCTY stock price fell by 7.03% during pre-market trading. The9...

The Dixie Group Inc. (DXYN) stock surged during pre-market trading given no recent news

The Dixie Group Inc. (NASDAQ: DXYN) stock gained by 11.55% in the pre-market trading session. However, there is no update available regarding this hike...

Why BancorpSouth Bank (BXS) stock plummeted on Friday?

BancorpSouth Bank (BXS) shares plummeted 9.39% in after-hours on Friday, June 18, 2021, and close the weekly business at $25.00 per share. Earlier, BXS's...

CureVac Inc. (CVAC) stock soar during pre-market trading. Here’s what you should know?

CureVac Inc. (NASDAQ: CVAC) stock declined by 38.99% at the last close while the CVAC stock price gains by 11.34% in the pre-market trading...

Anavex Inc. (AVXL) stock soars during pre-market trading. Let’s see why?

Anavex Inc. (AVXL) stock gained by 4.29% at the last close while the AVXL stock price surged by 12.38% in the pre-market trading session....

The9 Ltd. (NCTY) stock declined during pre-market trading. Here’s the update

The9 Ltd. (NASDAQ: NCTY) stock plunged by 12% at the last close while the NCTY stock price fell by 7.03% during pre-market trading. The9...

The Dixie Group Inc. (DXYN) stock surged during pre-market trading given no recent news

The Dixie Group Inc. (NASDAQ: DXYN) stock gained by 11.55% in the pre-market trading session. However, there is no update available regarding this hike...

Related News

Ocugen Inc. (NASDAQ:OCGN) stock plunged in the premarket trading session; here’s why

At last check Ocugen Inc. (OCGN) stock had plunged by-11.92% to $9.61 in premarket trading session. OCGN stock previously closed at $10.91 losing -12.79%....

KeyBanc reiterates Magna International [MGA] rating to Overweight and sets new price target at $86

KeyBanc maintained its Magna International rating to the equivalent of Overweight but changed the price target to $86.0 from $72, in a research...

Jefferies upgrades Medifast [MED] to Buy rating with a $265 price target

Jefferies took its Medifast rating to the equivalent of Buy from Hold, and the price target to $265.0 from $205, in a research...

American Eagle Outfitters [AEO] Upgraded to Outperform at RBC Capital

RBC Capital took its American Eagle Outfitters rating to the equivalent of Outperform from Sector Perform, and the price target to $30.0 from...

KeyBanc reiterates Nike [NKE] rating to Overweight and sets new price target at $180

KeyBanc maintained its Nike rating to the equivalent of Overweight but changed the price target to $180.0 from $174, in a research note...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.

Get Notified Of Insider Trades, Analyst Upgrades & Downgrades, Earnings Updates & Best Stocks To Trade Every Single Morning

100% free. stop anytime no spam